AstronauTx secures UCLTF investment for dementia therapeutics

AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of astrocytes for the treatment of Alzheimer’s disease, Dementia and other neurodegenerative diseases, today announces £1 million investment from the UCL Technology Fund to enable the development of translatable biomarkers for their drug discovery programs.